Incyte has expanded its support for projects tackling unmet needs to cover hidradenitis suppurativa (HS) patients, tightening its ties to the community ahead of filings for approval in the indication.
Please provide your email address to receive an email when new articles are posted on . There are multiple treatments for hidradenitis suppurativa, including two procedures and three biologics.
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
- New awareness campaign features authentic, often misunderstood, stories from people living with hidradenitis suppurativa (HS), highlighting the emotional and physical impact of the condition Incyte ...
GLP-1 weight loss and diabetes drugs, like Ozempic and Wegovy, have been shown to reduce the symptoms of a painful skin condition. Hidradenitis suppurativa, also known as acne inversa, is a condition ...
Panelists discuss the timely initiation of biologic therapy in moderate to severe hidradenitis suppurativa, emphasizing individualized treatment decisions based on disease impact and quality of life, ...
Panelists discuss the significant disparities in hidradenitis suppurativa diagnosis and care, emphasizing the impact of race, gender, geography, and socioeconomic status, and highlighting the need for ...
Please provide your email address to receive an email when new articles are posted on . HS unroofing for certain anatomic locations increased by as much as 116%. Dermatologists must help guide ...
Seventy-four percent of respondents unaware of FDA-approved treatments; 56% said these options had not been discussed by clinician. HealthDay News — The rates of respondent dissatisfaction with ...
Anisa Arsenault is the senior editorial director of the Health Group brands at People Inc. She previously managed news for Verywell Health. Imagine skin wounds painful enough to make sitting down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results